Community Health Worker Program for Heart Failure

N/A

Recruiting

Research Sponsored by Henry Ford Health System

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months

Awards & highlights

No Placebo-Only Group

Summary

This trialaims to reduce health disparities & Black-White lifespan inequality with CHWs delivering an evidence-based program to mitigate risk factors for heart failure, hypertension & coronary heart disease.

Who is the study for?

This trial is for self-identified Black/African American adults living in the Detroit area with high blood pressure or additional heart failure risk factors. It's not for those with uncontrolled diabetes, resistant hypertension, current pregnancy plans, previous heart failure diagnosis, multiple anti-diabetic drugs use, or extremely high blood pressure.

What is being tested?

The ACHIEVE-HF project tests an intervention program called PAL2 delivered by Community Health Workers to reduce health disparities in managing heart failure and high blood pressure among African Americans in Detroit and Cleveland.

What are the potential side effects?

Since this trial involves a non-drug intervention (PAL2), traditional medication side effects are not applicable. However, participants may experience stress or discomfort from lifestyle changes or monitoring required by the program.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

NT-proB-type Natriuretic Peptide (NT-proBNP)

Systolic blood pressure (BP)

Secondary study objectives

Geospatial outreach

Pharmaceutical Preparations

Other study objectives

BP Control (<130/80)

Change in creatinine

Body Weight Changes

+6 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention GroupExperimental Treatment2 Interventions

PAL2 Intervention Drug Therapy

Group II: Usual Care GroupActive Control1 Intervention

Participants that are randomized into usual care will be assisted with arrangement of follow-up, either with existing primary care provider (PCP) or a Wayne Health provider. All subsequent medical treatment will be at the discretion of the PCP.

Do I qualify?Apply below to find out